.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Deloitte
QuintilesIMS
Daiichi Sankyo
Baxter
Farmers Insurance
Harvard Business School
Johnson and Johnson
Colorcon
Teva

Generated: September 22, 2017

DrugPatentWatch Database Preview

Patents Expiring in January 2028

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Mobius Therap
MITOSOL
mitomycin
FOR SOLUTION;TOPICAL022572-001Feb 7, 2012RXYesYes► Subscribe► SubscribeYY
Dow Pharm
JUBLIA
efinaconazole
SOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes► Subscribe► Subscribe
Janssen Prods
YONDELIS
trabectedin
POWDER;IV (INFUSION)207953-001Oct 23, 2015RXYesYes► Subscribe► SubscribeY
Horizon Pharma
RAYOS
prednisone
TABLET, DELAYED RELEASE;ORAL202020-003Jul 26, 2012ABRXYesYes► Subscribe► SubscribeY TREATMENT OF RHEUMATOLOGIC, ALLERGIC, PULMONARY,GASTROINTESTINAL,DERMATOLOGIC DISEASES OR CONDITIONS BY THE USE OF A DELAYED RELEASE 5MG PREDNISONE TABLET
Apil
ATELVIA
risedronate sodium
TABLET, DELAYED RELEASE;ORAL022560-001Oct 8, 2010ABRXYesYes► Subscribe► SubscribeY TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
Apil
ATELVIA
risedronate sodium
TABLET, DELAYED RELEASE;ORAL022560-001Oct 8, 2010ABRXYesYes► Subscribe► SubscribeY TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
Takeda Pharms Usa
DEXILANT
dexlansoprazole
CAPSULE, DELAYED RELEASE;ORAL022287-002Jan 30, 2009ABRXYesYes► Subscribe► SubscribeY
Takeda Pharms Usa
DEXILANT
dexlansoprazole
CAPSULE, DELAYED RELEASE;ORAL022287-001Jan 30, 2009RXYesNo► Subscribe► SubscribeY
Shionogi Inc
SYMPROIC
naldemedine tosylate
TABLET;ORAL208854-001Mar 23, 2017RXYesYes► Subscribe► SubscribeYY
Astrazeneca Ab
BYDUREON PEN
exenatide synthetic
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200-002Feb 28, 2014RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Colorcon
Fuji
Baxter
Chinese Patent Office
Mallinckrodt
Medtronic
Covington
Cerilliant
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot